“Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).”, Transplantation, vol. 72, no. 6, pp. 1020-4, 2001.
, “Living-unrelated renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, Pediatr Transplant, vol. 2, no. 2, pp. 139-44, 1998.
, “2008 Update on Allogeneic Islet Transplantation from the Collaborative Islet Transplant Registry”, in The Transplantation Society Annual Meeting, Sydney Australia, 2008, 2Snd ed., vol. 86.
, “2008 Update from the Collaborative Islet Transplant Registry”, Transplantation, vol. 86, pp. 1783-1788, 2008.
, “Predictiveness of Positive C-peptide for Outcomes of Islet Transplantation”, Xenotransplantation, vol. 16, pp. 286–329, 2009.
, “Improvement in Outcomes of Islet Transplantation: CITR 1999-2008”, Xenotransplantation, vol. 16, pp. 286-329, 2009.
, “2008 Update from the Collaborative Islet Transplant Registry.”, Transplantation, vol. 86, no. 12, pp. 1783-8, 2008.
, , “Evaluation of pre- and post-transplant DST/CsA in non-HLA identical living donor kidney transplant recipients”, Transplantation, vol. 68, pp. 1117-24, 1999.
, “The influence of immunomodulatory diets on transplant success and complications.”, Transplantation, vol. 79, no. 4, pp. 460-5, 2005.
, “The Influence of Immunomodulatory Diets on Transplant Success and Complications”, Transplantation, vol. 79, pp. 460-465, 2005.
, “Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.”, Transplantation, vol. 68, no. 8, pp. 1117-24, 1999.
, “Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.”, Blood, vol. 132, no. 13, pp. 1438-1451, 2018.
, “Implications of Modifying Study Eligibility Criteria Post-Initiation of Recruitment”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Trial-related discrimination in HIV vaccine clinical trials”, AIDS Res HumRetroviruses, vol. 17, pp. 667-74, 2001.
, “Trial-related discrimination in HIV vaccine clinical trials.”, AIDS Res Hum Retroviruses, vol. 17, no. 8, pp. 667-74, 2001.
, “Late Effects after Umbilical Cord Blood Transplantation in Very Young Children after Busulfan-Based, Myeloablative Conditioning.”, Biol Blood Marrow Transplant, vol. 22, no. 9, pp. 1627-1635, 2016.
, “Factors Predicting Health Related Quality of Life in Pediatric Liver Transplant Recipients in the Functional Outcomes Group”, Pediatr Transplant, vol. 17, pp. 605-611, 2013.
, “Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients.”, J Pediatr, vol. 156, no. 2, pp. 270-6.e1, 2010.
, “Factors predicting health-related quality of life in pediatric liver transplant recipients in the functional outcomes group.”, Pediatr Transplant, vol. 17, no. 7, pp. 605-11, 2013.
, “Studies of pediatric liver transplantation. School attendance and growth of school age children following liver transplantation”, Transplantation, vol. 69, p. S307, 2000.
, “Linear growth patterns in prepubertal children following liver transplantation.”, Am J Transplant, vol. 9, no. 6, pp. 1389-97, 2009.
, “Cross-sectional Analysis of Health Related Quality of Life in Pediatric Liver Transplant Recipients”, J Pediatr, vol. 156, pp. 270-276.e271, 2010.
, , ,